Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Clinical trial NCT04467801 · UNKNOWN
Trial details
- NCT number
- NCT04467801
- Sponsor
- Jun Zhang, MD, PhD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2024-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.